Treatment of liver tumors with lipiodol TACE: technical recommendations from experts opinion

T de Baere, Y Arai, R Lencioni, JF Geschwind… - Cardiovascular and …, 2016 - Springer
Abstract Transarterial chemoembolization with Lipiodol (Lipiodol TACE), also called
conventional TACE, was developed in the early 1980s and widely adopted worldwide after …

[HTML][HTML] Immune checkpoint inhibitors in the treatment of HCC

C Donisi, M Puzzoni, P Ziranu, E Lai, S Mariani… - Frontiers in …, 2021 - frontiersin.org
Hepatocellular carcinoma (HCC) is the typical inflammation-induced neoplasia. It often
prospers where a chronic liver disease persists, thus leading a strong rationale for immune …

[HTML][HTML] Clinical, dosimetric, and reporting considerations for Y-90 glass microspheres in hepatocellular carcinoma: updated 2022 recommendations from an …

R Salem, SA Padia, M Lam, C Chiesa, P Haste… - European Journal of …, 2023 - Springer
Purpose In light of recently published clinical reports and trials, the TheraSphere Global
Dosimetry Steering Committee (DSC) reconvened to review new data and to update …

Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients

AS Kennedy, WA Dezarn, P McNeillie… - American journal of …, 2008 - journals.lww.com
Purpose: The use of 90 Y-microspheres to treat unresectable liver metastases originating
from a variety of neuroendocrine tumors was reviewed. Materials and Methods: This is a …

Clinical and dosimetric considerations for Y90: recommendations from an international multidisciplinary working group

R Salem, SA Padia, M Lam, J Bell, C Chiesa… - European journal of …, 2019 - Springer
Abstract The TheraSphere Global Dosimetry Steering Committee was formed in 2017 by
BTG International to review existing data and address gaps in knowledge related to …

99mTc-macroaggregated albumin poorly predicts the intrahepatic distribution of 90Y resin microspheres in hepatic radioembolization

M Wondergem, MLJ Smits, M Elschot… - Journal of Nuclear …, 2013 - Soc Nuclear Med
In hepatic 90Y radioembolization, pretreatment 99mTc-macroaggregated albumin (99mTc-
MAA) nuclear imaging is used for lung shunt analysis, evaluation of extrahepatic deposition …

Recommendations of the American Association of Physicists in Medicine on dosimetry, imaging, and quality assurance procedures for 90Y microsphere …

WA Dezarn, JT Cessna, LA DeWerd, W Feng… - Medical …, 2011 - Wiley Online Library
Yttrium‐90 microsphere brachytherapy of the liver exploits the distinctive features of the liver
anatomy to treat liver malignancies with beta radiation and is gaining more wide spread …

Complications following radioembolization with yttrium-90 microspheres: a comprehensive literature review

A Riaz, RJ Lewandowski, LM Kulik, MF Mulcahy… - Journal of Vascular and …, 2009 - Elsevier
The past decade has seen significant advancement in the locoregional management of liver
tumors; novel and promising therapies such as transarterial chemoembolization …

[HTML][HTML] Side effects of yttrium-90 radioembolization

A Riaz, R Awais, R Salem - Frontiers in oncology, 2014 - frontiersin.org
Limited therapeutic options are available for hepatic malignancies. Image guided targeted
therapies have established their role in management of primary and secondary hepatic …

Transcatheter intraarterial therapies: rationale and overview

RJ Lewandowski, JF Geschwind, E Liapi, R Salem - Radiology, 2011 - pubs.rsna.org
Transcatheter intraarterial therapies have proved valuable in the battle against primary and
secondary hepatic malignancies. The unique aspects of all such therapies are their reduced …